We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

35 hedge funds and large institutions have $7.19M invested in Albireo Pharma Inc in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

12% less capital invested

Capital invested by funds: $8.19M → $7.19M (-$999K)

15% less funds holding

Funds holding: 41 → 35 (-6)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

67% less call options, than puts

Call options by funds: $21K | Put options by funds: $64K

Holders
35
Holders Change
-6
Holders Change %
-14.63%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
14
Reduced
8
Closed
9
Calls
$21K
Puts
$64K
Net Calls
-$43K
Net Calls Change
+$22K

Top Buyers

Rank Fund Capital Flow
1
FMA
FNY Managed Accounts
New York
+$417K
2
SM
Sabby Management
Florida
+$179K
3
Renaissance Technologies
Renaissance Technologies
New York
+$172K
4
William Blair & Company
William Blair & Company
Illinois
+$96.5K
5
Group One Trading
Group One Trading
Illinois
+$56.5K

Top Sellers

Rank Fund Capital Flow
1
FNYS
First New York Securities
New York
-$453K
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$66.5K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$62.6K
4
Nomura Holdings
Nomura Holdings
Japan
-$48K
5
RA
Royce & Associates
New York
-$34K
Name Holding Trade Value Shares
Change 		Change in
Stake
NPC
26
National Planning Corporation
California
$3.63K +$3.64K +83 New
SM
27
Sabby Management
Florida
$2.15K +$179K +4,078 +8%
PMFA
28
Plante Moran Financial Advisors
Michigan
$2K – – –
LTFS
29
Ladenburg Thalmann Financial Services
Florida
$1K -$11.7K -267 -89%
Morgan Stanley
30
Morgan Stanley
New York
$1K -$1.84K -42 -53%
Citigroup
31
Citigroup
New York
$1K -$1.1K -25 -50%
Creative Planning
32
Creative Planning
Kansas
$1K – – –
Bank of America
33
Bank of America
North Carolina
$1K +$44 +1 +4%
FNYS
34
First New York Securities
New York
– -$453K -9,041 Closed
Nomura Holdings
35
Nomura Holdings
Japan
– -$48K -967 Closed
RA
36
Royce & Associates
New York
– -$34K -670 Closed
TC
37
TFS Capital
Pennsylvania
– -$23K -467 Closed
PAG
38
Private Advisor Group
New Jersey
– -$22K -433 Closed
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
– -$18K -357 Closed
TRCT
40
Tower Research Capital (TRC)
New York
– -$3K -51 Closed
Wells Fargo
41
Wells Fargo
California
– -$2K -46 Closed
MFS
42
MSI Financial Services
Massachusetts
– -$1K -11 Closed
AIM
43
Advantage Investment Management
Iowa
– +$351 +8 New
1
2

ALBO Hedge Fund Activity: Q4 2014 in Review

35 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q4 2014, worth a combined $7.19M — down 12% from $8.19M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ALBO and 4 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 14 added.

The largest buyer was FNY Managed Accounts, adding an estimated $417K. The largest seller was First New York Securities, exiting entirely with an estimated $453K sold.

  • 35 institutional investors held Albireo Pharma Inc (ALBO) as of Q4 2014, down from 41 in Q3 2014.
  • Funds reported $7.19M of Albireo Pharma Inc stock for Q4 2014, down 12% quarter-over-quarter.
  • 4 funds opened new Albireo Pharma Inc positions in Q4 2014 and 9 closed out, a net change of -5 holders.
  • The largest Albireo Pharma Inc buyer in Q4 2014 was FNY Managed Accounts, an estimated $417K added.
  • The largest Albireo Pharma Inc seller in Q4 2014 was First New York Securities, an estimated $453K sold.

Based on aggregated 13F filings for Q4 2014.